| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/25/2003 | EP1140110B1 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
| 06/25/2003 | EP1140019B1 Aerosol formulations for buccal and pulmonary application |
| 06/25/2003 | EP1088315B1 Nucleation and growth of magnetic metal oxide nanoparticles and its use |
| 06/25/2003 | EP1069915B1 Hydroxylation activated drug release |
| 06/25/2003 | EP0971703B1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 06/25/2003 | EP0744958B1 Polyclonal antibody libraries |
| 06/25/2003 | EP0727984B1 Controlled release preparation |
| 06/25/2003 | CN1426424A Compound comprising crosslinked polyrotaxane |
| 06/25/2003 | CN1426311A Medicament for stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and method for production thereof |
| 06/25/2003 | CN1426307A 蛋白质 Protein |
| 06/25/2003 | CN1426305A Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract |
| 06/25/2003 | CN1426300A Urea-containing gel preparation |
| 06/25/2003 | CN1426298A 组合物 The composition |
| 06/25/2003 | CN1426297A Directly compressed solid dosage particles |
| 06/25/2003 | CN1425706A Polyglycol block modified polyhexanolactone and its preparing method |
| 06/25/2003 | CN1112429C Water soluble concentrate obtained from emulgator or water-solubilising phase and complex of liquid lipophile substances of plant origin |
| 06/25/2003 | CN1112216C Use of carboxymethyl starch sodium as disintegrant in dispersant sheet |
| 06/25/2003 | CN1112185C Solid medicinal composition containing ecipient capable of combining water |
| 06/25/2003 | CN1112180C Pharmaceutical composition containing drug/beta-cyclodextrin complex in combinection with acid-base couple |
| 06/24/2003 | US6583301 Lipids |
| 06/24/2003 | US6583272 Protein conjugate for use in the treatment of blood disorders |
| 06/24/2003 | US6583219 Three-dimensional, crosslinked interpenetrating polymer network |
| 06/24/2003 | US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper |
| 06/24/2003 | US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid |
| 06/24/2003 | US6583164 Lyophilized imidazole-1-yl or 1,2,4-triazole-1-yl quaternized with a alklycarbonyloxy alkyl group eliminated in vivo; a saccharide; 4-acetoxymethyl-1-(3-(2-oxo-3-(4-(1H-tetrazol-yl) phenyl)-1-imidazolydinyl)butyl)-1H-1,2,4-triazolium chloride |
| 06/24/2003 | US6583125 Antiulceration effective amount of a substituted cyclodextrin compound and a cytotoxic drug, especially an anticancer drug; side effect reduction |
| 06/24/2003 | US6583124 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye |
| 06/24/2003 | US6582926 Solid support for use as analytical tool in genetic engineering |
| 06/24/2003 | US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 06/24/2003 | US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids |
| 06/24/2003 | US6582738 Process for preparing chewing gum containing a nutritional supplement |
| 06/24/2003 | US6582737 Pharmaceutical composition containing two active ingredients for smoking cessation |
| 06/24/2003 | US6582729 By including water soluble polypeptide; administered by inhalation |
| 06/24/2003 | US6582727 Two halves of the capsule will fuse together during the filling and cutting process under pressurization and high heat |
| 06/24/2003 | US6582724 Enhancing permeation of skin or mucosal tissue with topical hydroxide- releasing agent and lipophilic co-enhancer |
| 06/24/2003 | US6582721 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 06/24/2003 | US6582718 Topical, ophthalmic cyclosporin A formulation having better distribution due to surfactant (polyoxyethylene fatty acid esters) causing less irritation to the eyes |
| 06/24/2003 | US6582717 Drug delivery composition and device |
| 06/24/2003 | US6582710 Products for topical applications comprising oil bodies |
| 06/24/2003 | US6582700 Linear antigen supporting units |
| 06/24/2003 | US6582697 Administering a synthetic conjugate comprising a carbohydrate antigenic determinant and an immunogenic carrier not naturally conjugated with said determinant; tumor prophylaxis and therapy for example |
| 06/24/2003 | US6582683 Dermal barrier composition |
| 06/24/2003 | US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood |
| 06/24/2003 | CA2343439C Compositions useful in the treatment of diseases of connective tissues |
| 06/24/2003 | CA2012311C New protein-polycation-conjugate |
| 06/19/2003 | WO2003050502A2 Prospective identification and characterization of breast cancer stem cells |
| 06/19/2003 | WO2003050283A2 A structure for presenting desired peptide sequences |
| 06/19/2003 | WO2003050271A2 In vitro production of dendritic cells from cd14+ monocytes |
| 06/19/2003 | WO2003050260A2 Streptavidin expressed gene fusions and methods of use thereof |
| 06/19/2003 | WO2003050257A2 Targeting leukemia cells |
| 06/19/2003 | WO2003050190A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 06/19/2003 | WO2003050076A1 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof |
| 06/19/2003 | WO2003049846A1 Method for preparing a multiple water/oil/water emulsion |
| 06/19/2003 | WO2003049804A2 Treatment of genitourinary tract disorders |
| 06/19/2003 | WO2003049783A2 Device and methods for harvesting tissue samples of known geometry |
| 06/19/2003 | WO2003049774A1 Transdermal transport of compounds |
| 06/19/2003 | WO2003049772A2 Guanidinium transport reagents and conjugates |
| 06/19/2003 | WO2003049764A1 Composition for viral preservation |
| 06/19/2003 | WO2003049763A1 Composition for the preservation of viruses |
| 06/19/2003 | WO2003049760A1 Compositions and method for treating hepatitis virus infection |
| 06/19/2003 | WO2003049733A1 High-concentration stable meloxicam solutions for needle-less injection |
| 06/19/2003 | WO2003049731A1 Process for affecting neurologic progression |
| 06/19/2003 | WO2003049721A1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/19/2003 | WO2003049719A2 Matrices for stabilizing and controlled release of problematic substances |
| 06/19/2003 | WO2003049718A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 06/19/2003 | WO2003049716A1 Stable topical formulation of clarithromycin |
| 06/19/2003 | WO2003049699A2 Novel monofunctional polyethylene glycol aldehydes |
| 06/19/2003 | WO2003049684A2 Pseudo-antibody constructs |
| 06/19/2003 | WO2003049680A2 Compositions containing both sedative and non-sedative antihistamines |
| 06/19/2003 | WO2003049667A2 The method of treating cancer |
| 06/19/2003 | WO2003049637A2 In situ bonds |
| 06/19/2003 | WO2003049626A1 Method and apparatus for production of a skin graft and the graft produced thereby |
| 06/19/2003 | WO2003049593A2 Prevention of flap necrosis in plastic surgery |
| 06/19/2003 | WO2003035002A3 Management of postoperative pain |
| 06/19/2003 | WO2003028767A3 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods |
| 06/19/2003 | WO2003013438A3 Nutrient therapy for immuno-compromised patients |
| 06/19/2003 | WO2003004096A3 Method and composition for prolonging the residence time of drugs in the gut |
| 06/19/2003 | WO2003003999A3 Delivery of a bioactive material |
| 06/19/2003 | WO2002051429A3 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages |
| 06/19/2003 | WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 06/19/2003 | US20030114724 Polyubiquitin based hydrogel and uses thereof |
| 06/19/2003 | US20030114647 Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules |
| 06/19/2003 | US20030114537 Medical combinations comprising mometasone and salmeterol |
| 06/19/2003 | US20030114536 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof |
| 06/19/2003 | US20030114532 Contacting human or nonhuman animal skin or hair with a compound containing 1-(3-methoxybenzyl)-3-substituted thiourea for for inhibiting free radical degradation |
| 06/19/2003 | US20030114527 Administering an immediate release tablets containing 400 mg of 5-methyl-2-(2'- chloro-6'-fluoroanilino)phenylacetic acid or salts to a patient for the treatment of cyclooxygenase-2 mediated diseases |
| 06/19/2003 | US20030114518 A conjugated drug with polyamideether copolymer including polylactams and polyether; nontoxic, drug delivery, sustained release |
| 06/19/2003 | US20030114497 Pharmaceutical compositions of amlodipine and atorvastatin |
| 06/19/2003 | US20030114494 Storage stability; bioavailability; core containing ndrug, enteric overcoating |
| 06/19/2003 | US20030114476 High potency dihydroergotamine compositions |
| 06/19/2003 | US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 06/19/2003 | US20030114434 Extended duration light activated cancer therapy |
| 06/19/2003 | US20030114430 Aqueous solution; controlling flocculation; oxidation resistance |
| 06/19/2003 | US20030114428 Pharmaceutical compositions for the treatment of asthma |
| 06/19/2003 | US20030114406 Dihydrazide derivatized hyaluronic acid crosslinked to a nucleic acid to transfect a cell, e.g. heart cell, to encoding a protein, e.g., endotheilial growth factor, to increase angiogenesis; antiischemic agents |
| 06/19/2003 | US20030114404 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 06/19/2003 | US20030114397 Water soluble paclitaxel derivatives |
| 06/19/2003 | US20030114394 Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
| 06/19/2003 | US20030114385 Viral enzyme activated prototoxophores and use of same to treat viral infections |
| 06/19/2003 | US20030114368 Immunotoxins directed against malignant cells |